ISGlobal – Barcelona Institute for Global Health is a research center in international health whose ultimate goal is to help close the gaps in health disparities between and within different regions of the world. For this, we engage in knowledge generation, translation and implementation. ISGlobal is a WHO Collaborative Center for Malaria Control, Elimination and Eradication.
The Manhiça Health Research Centre (CISM), established in 1996 and represented by the Fundação Manhiça, a legal Mozambican entity established in 2008, aims at conducting and promoting health research in national priority health areas to safeguard the health of the most vulnerable populations.
ISGlobal and CISM are looking broadly for an experienced Site-Clinical Trial Investigator for the BOHEMIA clinical trial, to be conducted in Mopeia, Mozambique. Venue: Mopeia.
BOHEMIA is a Unitaid funded, 4-year project that combines evidence generation and stakeholder engagement to create an enabling environment for ivermectin as a first-inclass endectocide for malaria prevention.
This will be achieved by generating evidence to support a WHO policy recommendation, briefing and engagement of country and regional leaders and civil society in order to forge country ownership and create demand, as well as ensuring supply of quality product by enabling manufacturer engagement as suppliers of quality, high volume/low cost product sufficient for malaria indication.
Evidence generation will consist of two independently powered cluster-randomized clinical trials in Tanzania and Mozambique with analysis of impact on infection incidence, as well as supporting entomological outcomes. The project will be conducted over a total of four years, with the clinical trial active for 2 sequential years during the peak malaria season. The overall goal is to advance the development of a complementary vector control strategy to reduce malaria transmission.
→ Mais vagas em Mopeia
→ Todos anúncios de Barcelona Institute for Global Health
→ Explorar vagas de Investigation